
Michael D. Anderson
Examiner (ID: 10390, Phone: (571)270-5159 , Office: P/2433 )
| Most Active Art Unit | 2433 |
| Art Unit(s) | 2498, 2433, 2432 |
| Total Applications | 759 |
| Issued Applications | 575 |
| Pending Applications | 52 |
| Abandoned Applications | 146 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15512731
[patent_doc_number] => 10562941
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-18
[patent_title] => Pneumolysin mutants and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 15/527919
[patent_app_country] => US
[patent_app_date] => 2015-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 11
[patent_no_of_words] => 21047
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15527919
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/527919 | Pneumolysin mutants and methods of use thereof | Nov 19, 2015 | Issued |
Array
(
[id] => 12002147
[patent_doc_number] => 20170306302
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-10-26
[patent_title] => 'CODON OPTIMIZED POLYNUCLEOTIDE FOR HIGH LEVEL EXPRESSION OF CRM197'
[patent_app_type] => utility
[patent_app_number] => 15/523616
[patent_app_country] => US
[patent_app_date] => 2015-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6996
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15523616
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/523616 | Codon optimized polynucleotide for high level expression of CRM197 | Nov 16, 2015 | Issued |
Array
(
[id] => 11229857
[patent_doc_number] => 09457069
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-10-04
[patent_title] => 'Method for treating premature ejaculation with a botulinum neurotoxin'
[patent_app_type] => utility
[patent_app_number] => 14/942424
[patent_app_country] => US
[patent_app_date] => 2015-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9743
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14942424
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/942424 | Method for treating premature ejaculation with a botulinum neurotoxin | Nov 15, 2015 | Issued |
Array
(
[id] => 12832117
[patent_doc_number] => 20180169211
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => Peptides derived from acinetobacter baumannii and their use in vaccination
[patent_app_type] => utility
[patent_app_number] => 15/526219
[patent_app_country] => US
[patent_app_date] => 2015-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52034
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15526219
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/526219 | Peptides derived from acinetobacter baumannii and their use in vaccination | Nov 12, 2015 | Abandoned |
Array
(
[id] => 10634542
[patent_doc_number] => 09352029
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-31
[patent_title] => 'Yersinia spp. polypeptides and methods of use'
[patent_app_type] => utility
[patent_app_number] => 14/933899
[patent_app_country] => US
[patent_app_date] => 2015-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 3
[patent_no_of_words] => 25536
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 518
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14933899
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/933899 | Yersinia spp. polypeptides and methods of use | Nov 4, 2015 | Issued |
Array
(
[id] => 12057223
[patent_doc_number] => 20170333568
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-23
[patent_title] => 'GLYCOCONJUGATES AND METHODS FOR THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 15/522631
[patent_app_country] => US
[patent_app_date] => 2015-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17083
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15522631
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/522631 | Glycoconjugates and methods for their use | Oct 30, 2015 | Issued |
Array
(
[id] => 12051531
[patent_doc_number] => 20170327872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-16
[patent_title] => 'DETECTION METHOD'
[patent_app_type] => utility
[patent_app_number] => 15/522130
[patent_app_country] => US
[patent_app_date] => 2015-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 49777
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 24
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15522130
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/522130 | DETECTION METHOD | Oct 29, 2015 | Abandoned |
Array
(
[id] => 12543177
[patent_doc_number] => 10010593
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-03
[patent_title] => Recombinant
[patent_app_type] => utility
[patent_app_number] => 14/883557
[patent_app_country] => US
[patent_app_date] => 2015-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 80
[patent_no_of_words] => 26613
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14883557
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/883557 | Recombinant | Oct 13, 2015 | Issued |
Array
(
[id] => 10823756
[patent_doc_number] => 20160169921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'MODULATING BACTERIAL MAM POLYPEPTIDES IN PATHOGENIC DISEASE'
[patent_app_type] => utility
[patent_app_number] => 14/861709
[patent_app_country] => US
[patent_app_date] => 2015-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 40088
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14861709
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/861709 | Modulating bacterial MAM polypeptides in pathogenic disease | Sep 21, 2015 | Issued |
Array
(
[id] => 12205831
[patent_doc_number] => 20180051057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-22
[patent_title] => 'CYANOBACTERIA HAVING IMPROVED PHOTOSYNTHETIC ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 15/511602
[patent_app_country] => US
[patent_app_date] => 2015-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 53649
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15511602
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/511602 | CYANOBACTERIA HAVING IMPROVED PHOTOSYNTHETIC ACTIVITY | Sep 14, 2015 | Abandoned |
Array
(
[id] => 14818467
[patent_doc_number] => 10406219
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-09-10
[patent_title] => Multivalent
[patent_app_type] => utility
[patent_app_number] => 15/509381
[patent_app_country] => US
[patent_app_date] => 2015-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 40
[patent_no_of_words] => 14614
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15509381
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/509381 | Multivalent | Sep 7, 2015 | Issued |
Array
(
[id] => 10735947
[patent_doc_number] => 20160082097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-03-24
[patent_title] => 'NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 14/844989
[patent_app_country] => US
[patent_app_date] => 2015-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 30131
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14844989
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/844989 | NEISSERIAL VACCINE COMPOSITIONS COMPRISING A COMBINATION OF ANTIGENS | Sep 2, 2015 | Abandoned |
Array
(
[id] => 16648782
[patent_doc_number] => 10925936
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-23
[patent_title] => Vaccine pharmaceutical composition for cell-mediated immunity containing bisphosphonates
[patent_app_type] => utility
[patent_app_number] => 15/507443
[patent_app_country] => US
[patent_app_date] => 2015-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 13802
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507443
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/507443 | Vaccine pharmaceutical composition for cell-mediated immunity containing bisphosphonates | Sep 1, 2015 | Issued |
Array
(
[id] => 11276050
[patent_doc_number] => 09492522
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-11-15
[patent_title] => 'Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections'
[patent_app_type] => utility
[patent_app_number] => 14/842651
[patent_app_country] => US
[patent_app_date] => 2015-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 21967
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14842651
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/842651 | Compositions of vaccines and adjuvants and methods for the treatment of urinary tract infections | Aug 31, 2015 | Issued |
Array
(
[id] => 11948270
[patent_doc_number] => 20170252421
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'COMPOUNDS AGAINST RALSTONIA PICKETTII FOR USE IN THE TREATMENT OF INSULIN RESISTANCE, AND METHOD OF DIAGNOSIS OF INSULIN RESISTANCE'
[patent_app_type] => utility
[patent_app_number] => 15/506948
[patent_app_country] => US
[patent_app_date] => 2015-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 16113
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15506948
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/506948 | COMPOUNDS AGAINST RALSTONIA PICKETTII FOR USE IN THE TREATMENT OF INSULIN RESISTANCE, AND METHOD OF DIAGNOSIS OF INSULIN RESISTANCE | Aug 27, 2015 | Abandoned |
Array
(
[id] => 11520536
[patent_doc_number] => 09603917
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-28
[patent_title] => 'Immunologically active compositions'
[patent_app_type] => utility
[patent_app_number] => 14/833454
[patent_app_country] => US
[patent_app_date] => 2015-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 19372
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14833454
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/833454 | Immunologically active compositions | Aug 23, 2015 | Issued |
Array
(
[id] => 11684088
[patent_doc_number] => 09682120
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-06-20
[patent_title] => 'Compositions and methods for the treatment of disorders involving epithelial cell apoptosis'
[patent_app_type] => utility
[patent_app_number] => 14/833611
[patent_app_country] => US
[patent_app_date] => 2015-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 27591
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14833611
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/833611 | Compositions and methods for the treatment of disorders involving epithelial cell apoptosis | Aug 23, 2015 | Issued |
Array
(
[id] => 11949499
[patent_doc_number] => 20170253650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-09-07
[patent_title] => 'ANTI-PARASITIC COMPLEXES'
[patent_app_type] => utility
[patent_app_number] => 15/507173
[patent_app_country] => US
[patent_app_date] => 2015-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12668
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15507173
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/507173 | Anti-parasitic complexes | Aug 20, 2015 | Issued |
Array
(
[id] => 11943304
[patent_doc_number] => 20170247455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'TREATMENT OF CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND AN ANTI-CD137 ANTIBODY'
[patent_app_type] => utility
[patent_app_number] => 15/505299
[patent_app_country] => US
[patent_app_date] => 2015-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 23309
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15505299
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/505299 | TREATMENT OF CANCER USING A COMBINATION OF AN ANTI-PD-1 ANTIBODY AND AN ANTI-CD137 ANTIBODY | Aug 20, 2015 | Abandoned |
Array
(
[id] => 11901075
[patent_doc_number] => 09770495
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-26
[patent_title] => 'Immunogenic antigens from Aspergillus fumigatus'
[patent_app_type] => utility
[patent_app_number] => 14/824957
[patent_app_country] => US
[patent_app_date] => 2015-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 17
[patent_no_of_words] => 12978
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14824957
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/824957 | Immunogenic antigens from Aspergillus fumigatus | Aug 11, 2015 | Issued |